Clinical trial
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the…
NCT02762370 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT02762370 |
|---|---|
| Title | Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes |
| Official title | A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis of the Knee, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | FX006 32 mg, TCA IR 40 mg |
| Enrollment | 33 |
| Start date | Apr 1, 2016 |
| Primary completion | Oct 1, 2016 |
| Completion | Nov 1, 2016 |
| First posted | May 4, 2016 |
| Last update posted | Jan 24, 2024 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: